Khindivi™ (hydrocortisone) – New drug approval
May 28, 2025 - Eton Pharmaceuticals announced the FDA approval of Khindivi (hydrocortisone), as replacement therapy in pediatric patients 5 years of age and older with adrenocortical insufficiency.
Download PDF
